Friday February 24th 2017: Medtronic plc, MDT is in the exchange NYSE and its industry is Medical Appliances & Equipment in the sector of Healthcare. Based in USA, Medtronic plc, MDT has a market cap of 120.58 B. Since its IPO date on the 12/31/1981, Medtronic plc, MDT performance year to date is 23.66%. Today Medtronic plc, MDT has gained 0.48%, with a current price of 88.08.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 84.40%. The management of the company have seen the company have a payout ratio of 58.80%. Return of assets are at 4.10%, with return on investment at 5.70%.
In terms of debt levels and profit levels, Medtronic plc, MDT is seeing a long-term debt/equity of 0.52. While Total debt/equity is 0.66. With a profit margin of 13.60%, this is combined with a gross margin of 68.70%, and operating margin of 17.90%. Medtronic plc ability to meet debt levels, with a current ratio of 1.7, while the quick ratio is 1.5.
For the last year Medtronic plc, MDT has seen a EPS growth of 16.70%. A performance for the year of 4.13%. The 52-week high is -1.33%, and the 52-week low is 27.01%. The average volume for Medtronic plc, MDT is 5436765.
With a target price of 91.38, can Medtronic plc, MDT reach this target? Looking at the value indicators of Medtronic plc, MDT. Medtronic plc has a P/E of 30.4 and a forward P/E of 16.24. Perhaps the more useful indicator than P/E, is PEG which has a value of 4.12. Medtronic plc also has a P/S and a P/B of 4.06 and 2.4 respectively. For P/cash, Medtronic plc has a value of 8.8, while it is 37.1 for P/free cash flow.
At the current price of 88.08, Medtronic plc has a dividend yield of 1.95%. We see a return on equity of 8.00%.
Looking more long-term Medtronic plc, is projected to get an EPS growth for the next five years of 7.38%. In the short-term an EPS growth of 9.51% in the next year is forecasted. This is after a EPS growth of 16.70% for this year and for the last five years a -2.10% growth has been seen.